These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics. Mitchell PL; Evans BD; Allan SG; Forgeson GV; Mak D; Neave L; Humm G; Langley G; Dickson D; Harvey VJ N Z Med J; 1992 Mar; 105(929):73-5. PubMed ID: 1532054 [TBL] [Abstract][Full Text] [Related]
3. [Combined use of ondansetron and other anti-emetics to control cisplatin-induced nausea and vomiting]. Zeng WY Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):118-21. PubMed ID: 8223120 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents]. Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945 [TBL] [Abstract][Full Text] [Related]
5. Ondansetron: prevention of nausea & vomiting in cisplatin based chemotherapy. Cheirsilpa A; Ratanatharathorn V; Sinlarat P; Chindavijak K; Lousoontornsiri W; Chakrapee-Sirisuk S; Srimuninimit V J Med Assoc Thai; 1994 Apr; 77(4):201-6. PubMed ID: 7844494 [TBL] [Abstract][Full Text] [Related]
6. [Effects of intravenous and oral administration of ondansetron hydrochloride on chemotherapy-induced nausea and vomiting in patients with esophageal cancer]. Miyashita M; Onda M; Ikeda K; Bando K; Hagiwara N; Tsuchiya Y; Yoshiyuki T; Kiyama T; Saito T; Sasajima K; Yamashita K Gan To Kagaku Ryoho; 1999 Oct; 26(11):1629-35. PubMed ID: 10553422 [TBL] [Abstract][Full Text] [Related]
7. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children. Matera MG; Di Tullio M; Lucarelli C; Casale F; Calabria C; Lampa E; Indolfi P; Rossi F J Med; 1993; 24(2-3):161-70. PubMed ID: 7691978 [TBL] [Abstract][Full Text] [Related]
8. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors]. Seliuzhitskiĭ IV; Eliseev SN; Ivanov AI Voen Med Zh; 1994 Oct; (10):34-6. PubMed ID: 7831851 [No Abstract] [Full Text] [Related]
9. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy. Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140 [TBL] [Abstract][Full Text] [Related]
10. Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy. Tsavaris N; Kosmas C; Mylonakis N; Bacoyiannis C; Kalergis G; Vadiaka M; Boulamatsis D; Iakovidis V; Kosmidis P Anticancer Res; 2000; 20(6C):4777-83. PubMed ID: 11205218 [TBL] [Abstract][Full Text] [Related]
11. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin]. Tanimura S; Banba J; Tomoyasu H; Masaki M Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study]. Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M Gan To Kagaku Ryoho; 1992 Sep; 19(11):1905-14. PubMed ID: 1387776 [TBL] [Abstract][Full Text] [Related]
13. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist? Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106 [TBL] [Abstract][Full Text] [Related]
14. [Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo]. Ariyoshi Y; Ota K; Taguchi T; Furue H; Niitani H; Tsukagoshi S; Ikeda M; Akasaka Y; Ohta J; Suminaga M Gan To Kagaku Ryoho; 1992 Oct; 19(12):2057-70. PubMed ID: 1417014 [TBL] [Abstract][Full Text] [Related]
15. [Antiemetic effect of ondansetron in patients treated with combined antineoplastic regimens which include cisplatin]. Madej G; Pawiński A; Rogowski W; Skoneczna I Pol Tyg Lek; 1993 Jun 21-28; 48(25-26):560-2. PubMed ID: 8008650 [No Abstract] [Full Text] [Related]
16. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting. Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A J BUON; 2007; 12(2):245-52. PubMed ID: 17600880 [TBL] [Abstract][Full Text] [Related]
17. [Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]. Akasaka Y; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Ikeda M; Ohta J; Suminaga M Gan To Kagaku Ryoho; 1992 Aug; 19(9):1359-74. PubMed ID: 1386977 [TBL] [Abstract][Full Text] [Related]
18. Ondansetron in the treatment of nausea and vomiting induced by chemotherapy. Portuguese Ondansetron Study Group. Ribiero MM; de Faria L; dos Reis F; Fráguas A; de Matos E; Uva S; Ribeiro I; Brandão A; Ribeiro M; Batarda M Anticancer Drugs; 1993 Dec; 4 Suppl 2():23-7. PubMed ID: 8136512 [TBL] [Abstract][Full Text] [Related]
19. Parenteral ondansetron for the treatment of chemotherapy- and radiation-induced nausea and vomiting. Burnette PK; Perkins J Pharmacotherapy; 1992; 12(2):120-31. PubMed ID: 1533280 [TBL] [Abstract][Full Text] [Related]
20. [Cisplatin drug therapy. Antiemetic treatment. Experiences with the use of high-dose metoclopramide combined with chlopromazine and prochlorperazine]. Aasebø U; Myhr K Tidsskr Nor Laegeforen; 1985 Jan; 105(2):148-9. PubMed ID: 4038825 [No Abstract] [Full Text] [Related] [Next] [New Search]